Insider trade

Oric Pharmaceuticals (ORIC)CFO sold ~$4.5K

Dominic Piscitelli, CFO at Oric Pharmaceuticals, sold ~$4.5K of Oric Pharmaceuticals shares.

~$4.5K
Approx. value · 450 sh @ $10.01: 101K
Holds after · shares reported

Traded: Jun 23, 2025
Filed: Jun 24, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Jun 6, 2025InsiderCFO sold ~$26K of ORIC shares in the open market
Jun 9, 2025InsiderCFO sold ~$3K of ORIC shares in the open market
Jun 10, 2025InsiderCFO sold ~$3.2K of ORIC shares in the open market
Jun 11, 2025Insider · 1 personInsiders: 2 sales (~$30K)
Jun 12, 2025InsiderCFO sold ~$3K of ORIC shares in the open market
Jun 20, 2025InsiderDirector purchased ~$250K of ORIC shares in the open market
Jun 23, 2025 · this disclosureInsiderCFO sold ~$4.5K of ORIC shares in the open market

What came next

Jun 23, 2025Insider · 2 peopleInsiders: 1 purchase (~$13K), 1 sale (~$6K)
Jun 24, 2025InsiderCFO sold ~$341K of ORIC shares in the open market
Jul 1, 2025InsiderCFO sold ~$201K of ORIC shares in the open market
Sep 22, 2025Insider · Their largest sale since 2021CEO sold ~$1.35M of ORIC shares in the open market

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Oric Pharmaceuticals

For Oric Pharmaceuticals, OQRO holds 5 insider filings (SEC Form 4 or Form 144) and 3 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ORIC page.

Other recent filings by Dominic Piscitelli, Chief Financial Officer

The full history of Dominic Piscitelli, Chief Financial Officer is on the profile page.

How this filing works

Other disclosures at Oric Pharmaceuticals

Everything OQRO holds on this company is on its ORIC page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data